#United States #Louisville #Ginkgo Bioworks #Aura Genetics

Ginkgo Automation and Aura Genetics Join Forces

In a significant move within the healthcare industry, Ginkgo Bioworks (NYSE: DNA) has announced its partnership with Aura Genetics, a high-complexity diagnostic laboratory. This collaboration aims to revolutionize direct-to-consumer testing by implementing cutting-edge laboratory automation solutions.

Ginkgo's Automation Innovations

Ginkgo Automation is set to deploy its Reconfigurable Automation Cart (RAC) system at Aura Genetics' expansive 22,000-square-foot facility located at the UPS Healthcare Labport in Louisville, Kentucky. This advanced modular automation platform promises to enhance the efficiency of Aura Genetics' diagnostic testing workflows, enabling the lab to process a staggering number of samples daily. This revolutionary system combines real-time error resolution services and orchestration software to streamline laboratory operations.

Key Benefits of the Partnership

Will Serber, the General Manager of Ginkgo Automation, expressed pride in the collaboration, highlighting how the RAC system is designed to adapt to customer needs while boosting efficiency. The implementation of this technology solidifies Aura Genetics' commitment to innovation, allowing it to establish a new standard in laboratory testing. As the company looks to expand its capabilities, Serber noted the integral role of Ginkgo's engineering team in supporting this endeavor.

Anthony Nuccio, COO at Aura Genetics, emphasized that the partnership with Ginkgo represents a critical advancement for the company. With the integration of Ginkgo's sophisticated automation technologies, Aura Genetics aims to significantly reduce turnaround times for test results and introduce innovative testing solutions to the market more rapidly.

An Eye Towards the Future

The agreement will foster extensive collaboration between the two companies, focusing on joint protocol development and on-demand technical support. This cooperative environment reflects both organizations' dedication to quality, scientific integrity, and the relentless pursuit of innovation. With consumer demand for at-home testing on the rise, the partnership is poised to accelerate advancements in diagnostic capabilities while maintaining rigorous standards of accuracy and reliability.

Ginkgo Bioworks, widely recognized for its pioneering platform in cell programming and biosecurity, is dedicated to providing customizable solutions that cater to diverse sectors, including food, pharmaceuticals, and industrial chemicals. Similarly, Aura Genetics aims to redefine modern diagnostics with its same-day testing capabilities, significantly enhancing patient care and outcomes.

As the landscape of healthcare continues to evolve with technological advancements, this partnership is a promising step toward making high-quality diagnostic testing more accessible to consumers. By leveraging Ginkgo's expertise in automation and engineering, Aura Genetics is set to transform its operations and remain at the forefront of the industry.

Conclusion

The collaboration between Ginkgo Bioworks and Aura Genetics is a testament to the power of innovation in the field of healthcare. With an emphasis on operational efficiency and improved patient outcomes, this partnership is expected to pave the way for new standards in testing technology and consumer access to lab services. As the future unfolds, the industry will be watching closely to see how these advancements unfold in practice and impact healthcare delivery.